Omega Healthcare Investors (NYSE:OHI) Given New $52.00 Price Target at UBS Group

Omega Healthcare Investors (NYSE:OHI – Get Free Report) had its price objective cut by investment analysts at UBS Group from $54.00 to $52.00 in a report issued on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the real estate investment trust’s stock. UBS Group’s price objective points to a potential upside of 15.02% from the stock’s current price.

A number of other research analysts have also issued reports on OHI. Wells Fargo & Company reduced their price objective on Omega Healthcare Investors from $49.00 to $48.00 and set an “equal weight” rating for the company in a research report on Tuesday, September 1st. Weiss Ratings restated a “buy (b+)” rating on shares of Omega Healthcare Investors in a research note on Friday, September 25th. Raymond James Financial reaffirmed an “outperform” rating and issued a $53.00 target price on shares of Omega Healthcare Investors in a research report on Tuesday, October 6th. Cantor Fitzgerald raised their target price on Omega Healthcare Investors from $52.00 to $56.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Finally, Scotiabank reduced their price target on shares of Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating for the company in a report on Thursday, June 18th. Six investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Omega Healthcare Investors currently has an average rating of “Hold” and a consensus price target of $49.93.

Get Our Latest Report on Omega Healthcare Investors

Omega Healthcare Investors Trading Up 0.1%

NYSE OHI traded up $0.04 during trading hours on Tuesday, reaching $45.21. The company’s stock had a trading volume of 1,169,951 shares, compared to its average volume of 2,080,531. The business has a 50-day simple moving average of $46.51 and a 200 day simple moving average of $46.90. Omega Healthcare Investors has a 52 week low of $39.26 and a 52 week high of $52.39. The stock has a market cap of $13.70 billion, a PE ratio of 16.15, a PEG ratio of 1.79 and a beta of 0.53.

Omega Healthcare Investors (NYSE:OHI – Get Free Report) last posted its earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 EPS for the quarter, beating the consensus estimate of $0.51 by $0.68. The company had revenue of $328.25 million during the quarter, compared to analyst estimates of $266.97 million. Omega Healthcare Investors had a return on equity of 15.76% and a net margin of 66.96%. The business’s revenue was up 16.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.77 earnings per share. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. As a group, equities analysts predict that Omega Healthcare Investors will post 3.12 EPS for the current year.

Hedge Funds Weigh In On Omega Healthcare Investors

Hedge funds and other institutional investors have recently made changes to their positions in the business. Ascentis Independent Advisors bought a new position in Omega Healthcare Investors during the first quarter valued at about $35,000. Gunpowder Capital Management LLC dba Oliver Wealth Management acquired a new position in Omega Healthcare Investors during the fourth quarter worth about $37,000. MassMutual Private Wealth & Trust FSB raised its position in Omega Healthcare Investors by 53.3% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 906 shares of the real estate investment trust’s stock worth $43,000 after acquiring an additional 315 shares in the last quarter. Elevation Wealth Partners LLC raised its position in Omega Healthcare Investors by 645.2% in the second quarter. Elevation Wealth Partners LLC now owns 924 shares of the real estate investment trust’s stock worth $44,000 after acquiring an additional 800 shares in the last quarter. Finally, Tompkins Financial Corp bought a new stake in Omega Healthcare Investors in the third quarter worth about $46,000. 65.25% of the stock is currently owned by institutional investors and hedge funds.

About Omega Healthcare Investors

(Get Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) focused on healthcare facilities, with an emphasis on skilled nursing and assisted living properties. The company owns or invests in healthcare real estate and leases its properties to operators that provide care and related services to residents.

Omega generally uses long-term, predominantly triple-net lease arrangements, under which tenants are responsible for many property-level expenses, including maintenance, insurance and taxes.

See Also

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.